NCT05965713Completed
Fully Remote Use of IpsiHand Device in Hemiparetic Stroke
IpsiHand Device Use in Hemiparetic Stroke Population to Assess Home Based EEG System Candidacy for BCI Rehabilitation of the Upper Extremity and the Efficacy of a Full Remote Home Based BCI Therapy - A Randomized Control Trial
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
BCI-REHAB was a randomized clinical trial comparing an at-home brain-computer interface therapy system versus an at-home exercise program for upper-extremity rehabilitation in the chronic phases of stroke. The purpose of the trial was to evaluate the efficacy of BCI-based therapy tested against standard exercise therapy and assess the potential for meaningful motor improvement in the home environment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 109 (actual)
- First submitted
- 18 Jul 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 12 Sept 2025
- Lead sponsor
- Neurolutions, Inc.
- Diseases
- Stroke
- NCT number
- NCT05965713
What you commit to
- Study type: Interventional
- Participants enrolled: 109
- From 1 Oct 2023 to the primary completion date, 12 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who are not receiving Botox Injections for the upper extremity may be included. Should a participant be receiving Botox injections for the upper extremity, they may be included but Botox administration must be timed to coincide within a week of the beginning of training.
- Participants receiving any formal upper extremity therapy will be excluded.
Other illness
- Participants with ataxia apraxia or severe psychiatric illness (other than post stroke depression) will be excluded.
- Participants who have nerve or sensory impairment that may limit or interfere with their ability to sense pain will be excluded.
Other
- Participants who are too cognitively impaired to understand the task or provide informed consent will be excluded. A Short-Blessed Test score of 8 or more will be excluded.
- Participants who have contractures in the affected wrist and digits will be excluded, as the device will not comfortably fit.
- Participants who have receptive aphasia and unable to follow written directions will be excluded. A score of 6 or less on the MS Aphasia Screening Test will be excluded.
- Participants who are pregnant or breast-feeding will be excluded.
Who the study is looking for
- Adults age (18-85)
- Adults who sustained a CVA
- Have upper extremity hemiparesis/hemiplegia
- Participants who are not receiving Botox Injections for the upper extremity may be included. Should a participant be receiving Botox injections for the upper extremity, they may be included but Botox administration must be timed to coincide within a week of the beginning of training.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University in Saint Louis Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.